Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Avantor, Inc.AVTR · Entity 3546 | EVP and CFO | September 21, 2026 | September 23, 2026 |
| CONMED CorpCNMD · Entity 4691 | Executive Vice President & CFO | November 06, 2025 | November 07, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Avantor, Inc.
Report date September 21, 2026 · Filed September 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 49,688 |
Reported balance
After 2026-09-21 transaction · row 1
1 source rowRow 1 · 2026-09-21 · Grant · Acquired 49,688 · Balance 49,688 F1: Reflects a grant of restricted stock units that vest in two equal annual installments beginning on September 21, 2027. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.61 · Expires 2036-09-21 | Direct | 138,632 |
Reported balance
After 2026-09-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-21 · Grant · Acquired 138,632 · Balance 138,632 F2: Reflects a grant of stock options that vest in three equal annual installments beginning on September 21, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a grant of restricted stock units that vest in two equal annual installments beginning on September 21, 2027.
F2: Reflects a grant of stock options that vest in three equal annual installments beginning on September 21, 2027.
CONMED Corp
Report date November 06, 2025 · Filed November 07, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,836 |
Reported balance
After 2025-11-06 transaction · row 1
1 source rowRow 1 · 2025-11-06 · Sale · Disposed 3,500 · Balance 1,836 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 21, 2026 Filed Sep 23, 2026 20:30 UTC | Avantor, Inc. AVTR · Entity 3546 | GrantStock Options (Right to Buy) · Derivative | 138,632 | $0.00 Strike: $16.61 | $0.00 |
DisclosureSEC source: 0001628280-26-063227 · wk-form4_1790195401.xml · derivative · entry 2 Garner Todd W · CIK 0001726884 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,632 Underlying: Common Stock · 138,632 shares Expires 2036-09-21 F2 · derivative.exercise_date: Reflects a grant of stock options that vest in three equal annual installments beginning on September 21, 2027. Read SEC document |
| September 21, 2026 Filed Sep 23, 2026 20:30 UTC | Avantor, Inc. AVTR · Entity 3546 | GrantCommon Stock | 49,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-063227 · wk-form4_1790195401.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,688 F1 · kind: Reflects a grant of restricted stock units that vest in two equal annual installments beginning on September 21, 2027. Read SEC document |
| November 06, 2025 Filed Nov 7, 2025 21:06 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 3,500 | $43.00 | $150,500.00 |
DisclosureSEC source: 0000816956-25-000059 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,836 Read SEC document |
| October 31, 2025 Filed Nov 3, 2025 21:47 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRSUs (Restricted Stock Units) · Derivative | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000816956-25-000044 · form4.xml · derivative · entry 3 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,227 Underlying: Common Stock · 7,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company"). F2 · derivative.exercise_date: The RSUs are subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan vesting over two years with 33% vesting after year 1 and 67% vesting after year 2. F2 · derivative.expiration_date: The RSUs are subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan vesting over two years with 33% vesting after year 1 and 67% vesting after year 2. Read SEC document |
| October 31, 2025 Filed Nov 3, 2025 21:47 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 2,164 | $44.00 | $95,216.00 |
DisclosureSEC source: 0000816956-25-000044 · form4.xml · nonDerivative · entry 2 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,336 Read SEC document |
| October 31, 2025 Filed Nov 3, 2025 21:47 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000816956-25-000044 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2025 Filed Aug 8, 2025 19:05 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 598 | $52.45 | $31,365.10 |
DisclosureSEC source: 0000816956-25-000033 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| March 31, 2025 Filed Apr 8, 2025 21:06 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 371 | $57.37 | $21,284.27 |
DisclosureSEC source: 0001127602-25-011822 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 598 Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 20:36 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 61,475 | $0.00 Strike: $58.33 | $0.00 |
DisclosureSEC source: 0001127602-25-008267 · form4.xml · derivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,475 Underlying: Common Stock · 61,475 shares Expires 2035-03-03 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 19:26 UTC | CONMED Corp CNMD · Entity 4691 | GrantRSUs (Restricted Stock Units) · Derivative | 22,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-026454 · form4.xml · derivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,727 Underlying: Common Stock · 22,727 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company"). F2 · derivative.exercise_date: The RSUs are subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan vesting over two years with 33% vesting after year 1 and 67% vesting after year 2. F2 · derivative.expiration_date: The RSUs are subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan vesting over two years with 33% vesting after year 1 and 67% vesting after year 2. Read SEC document |
| March 28, 2024 Filed Apr 3, 2024 17:51 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 227 | $76.08 | $17,270.16 |
DisclosureSEC source: 0001127602-24-012125 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 227 Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:16 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 44,677 | $0.00 Strike: $79.95 | $0.00 |
DisclosureSEC source: 0001127602-24-008515 · form4.xml · derivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,677 Underlying: Common Stock · 44,677 shares Expires 2034-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| August 16, 2023 Filed Aug 17, 2023 22:26 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 1,355 | $112.00 | $151,759.73 |
DisclosureSEC source: 0001127602-23-022861 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.890 to $112.170. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:14 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 240 | $98.67 | $23,680.80 |
DisclosureSEC source: 0001127602-23-012179 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,355 Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:03 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 30,000 | $0.00 Strike: $50.61 | $0.00 |
DisclosureSEC source: 0001127602-23-010058 · form4.xml · derivative · entry 7 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,100 Underlying: Common Stock · 30,000 shares Expires 2028-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Each Stock Option represents a contingent right to receive one share of common stock, par value $0.001, per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (20%) over a five year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:03 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 100 | $92.63 | $9,263.00 |
DisclosureSEC source: 0001127602-23-010058 · form4.xml · nonDerivative · entry 6 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,115 Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:03 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 3,825 | $91.95 | $351,690.39 |
DisclosureSEC source: 0001127602-23-010058 · form4.xml · nonDerivative · entry 5 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,215 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.625 to $92.45. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:03 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 17,926 | $91.10 | $1,633,074.73 |
DisclosureSEC source: 0001127602-23-010058 · form4.xml · nonDerivative · entry 4 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,040 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.615 to $91.61. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:03 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 6,849 | $90.30 | $618,494.84 |
DisclosureSEC source: 0001127602-23-010058 · form4.xml · nonDerivative · entry 3 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,966 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.61 to $90.595. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:03 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 1,300 | $88.78 | $115,416.47 |
DisclosureSEC source: 0001127602-23-010058 · form4.xml · nonDerivative · entry 2 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,815 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.15 to $88.99. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:03 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 30,000 | $50.61 | $1,518,300.00 |
DisclosureSEC source: 0001127602-23-010058 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:13 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 32,212 | $0.00 Strike: $96.16 | $0.00 |
DisclosureSEC source: 0001127602-23-008912 · form4.xml · derivative · entry 4 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,212 Underlying: Common Stock · 32,212 shares Expires 2033-03-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:13 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008912 · form4.xml · derivative · entry 3 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,600 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:13 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 486 | $96.16 | $46,733.76 |
DisclosureSEC source: 0001127602-23-008912 · form4.xml · nonDerivative · entry 2 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,115 Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:13 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008912 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,601 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2022 Filed Dec 12, 2022 22:08 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 4,500 | $0.00 Strike: $50.61 | $0.00 |
DisclosureSEC source: 0001127602-22-027324 · form4.xml · derivative · entry 3 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,100 Underlying: Common Stock · 4,500 shares Expires 2028-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each Stock Option represents a contingent right to receive one share of common stock, par value $0.001, per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (20%) over a five year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018. Read SEC document |
| December 09, 2022 Filed Dec 12, 2022 22:08 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 4,500 | $89.31 | $401,895.00 |
DisclosureSEC source: 0001127602-22-027324 · form4.xml · nonDerivative · entry 2 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1 F1 · kind: The sale reported was effected pursuant to a previously adopted Rule 10b5-1 Trading Plan. Read SEC document |
| December 09, 2022 Filed Dec 12, 2022 22:08 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 4,500 | $50.61 | $227,745.00 |
DisclosureSEC source: 0001127602-22-027324 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2022 Filed Jul 7, 2022 19:37 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 1 | $90.97 | $90.97 |
DisclosureSEC source: 0001127602-22-019041 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1 Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 01:12 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 2,662 | $99.79 | $265,640.98 |
DisclosureSEC source: 0001127602-22-017504 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sale reported was effected pursuant to a previously adopted Rule 10b5-1 Trading Plan. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 20:47 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 168 | $141.12 | $23,708.16 |
DisclosureSEC source: 0001127602-22-011225 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,662 Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:16 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 55,000 | $0.00 Strike: $144.55 | $0.00 |
DisclosureSEC source: 0001127602-22-008100 · form4.xml · derivative · entry 4 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2032-03-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:16 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008100 · form4.xml · derivative · entry 3 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600 Underlying: Common Stock · 1,600 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:16 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 469 | $144.55 | $67,793.95 |
DisclosureSEC source: 0001127602-22-008100 · form4.xml · nonDerivative · entry 2 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,494 Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:16 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008100 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,963 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 22:03 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 2,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-000920 · form4.xml · derivative · entry 3 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2028-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.001 per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (25%) over a four year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 22:03 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 637 | $145.86 | $92,912.82 |
DisclosureSEC source: 0001127602-22-000920 · form4.xml · nonDerivative · entry 2 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,363 Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 22:03 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-000920 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 01:25 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 8,400 | $0.00 Strike: $50.61 | $0.00 |
DisclosureSEC source: 0001127602-21-026746 · form4.xml · derivative · entry 11 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,600 Underlying: Common Stock · 8,400 shares Expires 2028-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: Each Stock Option represents a contingent right to receive one share of common stock, par value $0.001, per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (20%) over a five year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 01:25 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 500 | $133.45 | $66,723.00 |
DisclosureSEC source: 0001127602-21-026746 · form4.xml · nonDerivative · entry 10 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.13 to $133.99. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 01:25 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 900 | $132.65 | $119,385.90 |
DisclosureSEC source: 0001127602-21-026746 · form4.xml · nonDerivative · entry 9 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.11 to $133.10. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 01:25 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 800 | $131.49 | $105,193.60 |
DisclosureSEC source: 0001127602-21-026746 · form4.xml · nonDerivative · entry 8 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.92 to $131.91. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 01:25 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 3,083 | $130.05 | $400,937.98 |
DisclosureSEC source: 0001127602-21-026746 · form4.xml · nonDerivative · entry 7 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,200 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.72 to $130.60. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 01:25 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 3,117 | $129.38 | $403,271.23 |
DisclosureSEC source: 0001127602-21-026746 · form4.xml · nonDerivative · entry 6 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,283 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.72 to $129.69. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 01:25 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 8,400 | $50.61 | $425,124.00 |
DisclosureSEC source: 0001127602-21-026746 · form4.xml · nonDerivative · entry 5 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: All of the exercises and sales submitted on this form were subject to a written 10b5-1 plan. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 01:25 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 32 | $132.99 | $4,255.52 |
DisclosureSEC source: 0001127602-21-026746 · form4.xml · nonDerivative · entry 4 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.79 to $133.15. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 01:25 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 20 | $131.63 | $2,632.50 |
DisclosureSEC source: 0001127602-21-026746 · form4.xml · nonDerivative · entry 3 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.34 to $131.91. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 01:25 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 81 | $130.13 | $10,540.45 |
DisclosureSEC source: 0001127602-21-026746 · form4.xml · nonDerivative · entry 2 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.75 to $130.72. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 01:25 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 58 | $129.33 | $7,500.97 |
DisclosureSEC source: 0001127602-21-026746 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.75 to $129.73. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:33 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 1,131 | $124.92 | $141,284.52 |
DisclosureSEC source: 0001127602-21-025499 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 15, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.